Menu

The Wall Street Journal's editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce the 340B program as “healthcare grift” in need of federal reform.

WSJ Editorial Board Op-Ed Points to North Dakota Judge’s Contract Pharmacy Ruling, Calls 340B ‘Scam’

May 12, 2026 Luke Zarzecki, National Correspondent 340B Report Views

A major newspaper’s editorial board recently highlighted a federal judge’s ruling against North Dakota’s contract pharmacy access law to denounce [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Luke Zarzecki

Louisiana AG Prepares Enforcement Action Against Drugmakers Under State 340B Contract Pharmacy Law

Federal Appeals Court Denies Novartis’ Rehearing Request on Mississippi’s 340B Contract Pharmacy Access Law